Clinical trial

HF Prevalence and Evolution of HF in DM II Patients at High Risk

NCT04482283

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-07-20

PhaseN/A

Study timeline

Study start (actual)2020-07-20Date precision: day

Registry last updated2025-11-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

RELATED REGISTRY SEARCHunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

AthensGreece4 ThessalonikiGreece2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04482283 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.